TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH ENTERIC COATED FORMULATIONS COMPRISING 5-AMINOSALICYLIC ACID OR 4-AMINOSALICYLIC ACID

摘要

Methods are disclosed for treating patients suffering from inflammatory bowel disease, including ulcerative colitis or Crohn's disease, by administering an oral or enema dosage form containing at least one aminosalicylate active ingredient. Granular dosage forms and kits are also disclosed.